MetaCap

Scribe Therapeutics (SCTX) Short Interest

NASDAQ: SCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

21.17+1.94 (+10.09%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Latest short interest · Sep 15, 2026

Change vs prior
+1.6%
Avg. daily volume
173.43K
Prior report
778.19K

Scribe Therapeutics short interest analysis

As of the Sep 15, 2026 settlement date, 790,538 SCTX shares were sold short, equal to 4.18% of Scribe Therapeutics's shares outstanding. That is up 1.6% from the previous report of 778.19K shares. With average daily volume of 173.43K shares, it would take about 4.6 trading days for short sellers to buy back their positions, which is moderate by typical standards.

Summary generated from market data by MetaCap's automated system. Methodology

SCTX short interest history

Scribe Therapeutics short interest by settlement date
SettlementShort InterestChange% Shares Out.Days to Cover
Sep 15, 2026790,538+1.6%4.18%4.56
Aug 31, 2026778,191+173.3%4.11%2.63
Aug 14, 2026284,711+8.2%1.50%2.14
Jul 31, 2026263,070+100.0%1.39%1.34

Days to cover = shares short ÷ average daily volume. Short percent uses total shares outstanding as the denominator, which is slightly lower than a float-based figure.

Frequently asked questions

What is Scribe Therapeutics's short interest?

SCTX short interest was 790,538 shares as of Sep 15, 2026, or 4.18% of shares outstanding, up 1.6% from the prior report.

What is SCTX's days to cover?

SCTX's days-to-cover (short interest ratio) is 4.56, meaning short sellers would need about 4.6 days of average trading volume to close their positions.

How often is short interest reported?

FINRA requires brokers to report short positions twice a month, as of mid-month and month-end settlement dates. The data is published about a week and a half after each settlement date, so it is always somewhat delayed.

Is high short interest bullish or bearish?

High short interest shows that many investors expect the price to fall, which is a bearish signal. It can also set up a short squeeze if the stock rises and short sellers rush to buy back shares. Neither outcome is guaranteed.

Related